Everyday Ordinary US Citizens will be Transformed into Criminals Over Night

UNITED STATES — The U.S. Drug Enforcement Administration is moving to classify concentrated 7-hydroxymitragynine (7-OH) as a Schedule I substance, sparking intense debate over criminalization and public health risks for regular users.

Introduction and History of 7-OH

7-OH is a psychoactive alkaloid naturally found in trace amounts within Mitragyna speciosa, a Southeast Asian tree commonly known as kratom.

While traditional kratom leaf has a history of localized use, recent commercial developments have led to the chemical extraction and synthetic manufacturing of 7-OH.

Various companies have developed concentrated 7-OH products — including tablets, liquid shots, and gummies — which are sold in various retail outlets. These concentrated forms significantly exceed the alkaloid levels typically found in raw plant material.

Pros and Cons of 7-OH Use

Reported Uses:

Some consumers report using these products for managing physical discomfort or as an alternative to other substances. The products have historically been accessible over-the-counter in many jurisdictions.

Associated Risks:

Health agencies, however, state that 7-OH possesses potent opioid-like receptor binding properties. The DEA and FDA have linked the substance to severe health risks, including potential respiratory depression, high potential for abuse, and physical dependence.

The market for these concentrated products is largely unregulated, leading to concerns regarding formulation consistency and unpredictable strength.

Legal Reclassification and Public Health Considerations

The DEA's intent to place concentrated 7-OH products into Schedule I would put these substances in the most restrictive regulatory category under federal law.

Once a final order takes effect, the manufacture, distribution, and possession of these concentrated products will be subject to federal criminal penalties.

Public health officials and advocacy groups have noted that this reclassification will impact individuals currently using these products.

Because 7-OH is described by health agencies as a potent opioid agonist, individuals with a physical dependence may experience significant withdrawal symptoms if access is abruptly terminated.

Health experts recommend that individuals seeking to discontinue use consult with medical professionals to manage potential health complications safely. To sign the petition, please visit the link provided below. Some have come to feel that maybe Public Enemy #1 is the US Government revolving around this particular issue? How do you feel about it? Making people that are already suffering, suffer more without the proper resources is just wrong.